Isomorphic Labs has raised a whopping $600 million to refine its artificial intelligence-powered drug discovery engine, advance its pipeline, and expand its headcount in its first external funding ...

Isomorphic Labs president Max Jaderberg said at WIRED Health in London that the startup has built a “broad and exciting ...

ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.

八岁那年，德米斯·哈萨比斯只能依稀瞥见星辰。 德米斯·哈萨比斯坐在位于伦敦大学学院天文台的弗莱望远镜前。图片来源：Jillian Edelstein for Fortune 这个天赋惊人的孩子成长于20世纪80年代的北伦敦，父母是颇具波西米亚气质的文艺青年。透过城市朦胧的光霭，哈萨比斯偶尔能够辨认出一个星座——猎户座。它得名于希腊神话中那位骁勇的猎人，千百年来一直是水手与农夫的星空路标。四十年后的 ...

Isomorphic Labs, the UK-based biotech spinoff of Google DeepMind, is set to begin human trials of drugs designed by its Nobel ...

Google DeepMind CEO, Demis Hassabis, envisions artificial intelligence replacing the traditional, lengthy drug discovery ...

Google DeepMind CEO Demis Hassabis says AI could redesign drug discovery, with Isomorphic Labs aiming to cut timelines, ...

Abstract: Graph isomorphism phenomenon has been identified since the 1930s, which was first addressed in the graph-theoretical field and was thoroughly studied as a critical topic of computer science.

Google parent Alphabet has drawn on its DeepMind artificial intelligence division to form a drug discovery unit that it calls Isomorphic Labs. The UK-registered company will be able to tap into ...

This repository is an official implementation of "HOMIE: Humanoid Loco-Manipulation with Isomorphic Exoskeleton Cockpit", which is a novel humanoid teleoperation cockpit composed of a humanoid ...

Isomorphic Labs, a spinoff of Google DeepMind, is preparing to begin clinical trials for drugs designed by its AI technology.